Table 1 Multiple reaction monitoring (MRM) transition table with parameters

From: Increased antioxidative defense and reduced advanced glycation end-product formation by metabolic adaptation in non-small-cell-lung-cancer patients

 

Parent m/z

Product m/z

Dwell time (ms)

Q1 pre bias (V)

CE

Q3 pre bias (V)

GSH

308

179

65

−11

−19

−23

GSSG

613

355

65.6

−14

−20

−25

GSH-NEM

433

304

65.6

−10

−17

−21

 

433

201

65.6

−16

−21

−21

GSH-d5-NEM

438

309

65.6

−10

−17

−21

 

438

206

65.6

−16

−21

−21

IS

441

312

100

−10

−17

−21

 

441

206

100

−16

−21

−21

sLG

380

223.05

100

−11

−18

−24

 

380

148.1

100

−11

−22

−30

 

380

76.05

100

−11

−37

−14

CysGly-NEM

304

287

65.6

−11

−14

−19

 

304

201

65.6

−11

−15

−21

CysGly-d5-NEM

309

292

65.6

−11

−14

−19

 

309

206

65.6

−11

−15

−21

Cys-NEM

247.11

230.05

65.6

−17

−14

−24

 

247.11

201.05

65.6

−14

−13

−21

Cys-d5-NEM

252.11

235.05

65.6

−17

−14

−24

 

252.11

206.05

65.6

−14

−13

−21

GluCys-NEM

376

247

65.6

−14

−15

−35

 

376

201.1

65.6

−14

−20

−20

GluCys-d5-NEM

381

252.05

65.6

−14

−15

−25

 

381

206.1

65.6

−14

−20

−20

HCys-NEM

261

56.05

65.6

−13

−16

−22

 

261

215.05

65.6

−13

−12

−23

HCys-d5-NEM

266

56.05

65.6

−13

−16

−22

 

266

222.05

65.6

−13

−12

−23

  1. CE collision energy, Q-quadrupole (GSH glutathione, GSSG glutathione disulfide, NEM N-ethylmaleimide, IS internal standard (13C14,N-GSH-d5-NEM), sLG S-lactoylglutathione, CysGly cysteinyl glycine, GluCys gamma glutamyl-cysteine, Cys cysteine, HCys homocysteine).